This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Sensorion S.A.

Drug Names(s): SENS401, SENS 401

Description: SENS-401 is a new drug candidate for treating vestibular and auditory disorders resulting from lesions of the inner ear.This drug is an enantiomer of SENS-218. SENS-401 is a small molecule that can be taken orally or via an injection.

SENS-401 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug